AstraZeneca unveils promising AI data for lung cancer detection, focuses on cost-effective solutions in resource-limited ...
AstraZeneca presented new data at the European Lung Cancer Congress (ELCC) 2025, demonstrating the potential of artificial intelligence (AI) in improving lung cancer risk detection, especially within resource-limited healthcare settings. The company …